RAPT Therapeutics (RAPT) Institutional Ownership $1.81 +0.08 (+4.62%) (As of 12/26/2024 05:41 PM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Institutional Ownership Changes (13F Filings) for RAPT Therapeutics (NASDAQ:RAPT)CurrentInstitutional OwnershipPercentage99.09%Number ofInstitutional Buyers(last 12 months)29TotalInstitutional Inflows(last 12 months)$51.69MNumber ofInstitutional Sellers(last 12 months)18TotalInstitutional Outflows(last 12 months)$41.99M Get RAPT Insider Trade Alerts Want to know when executives and insiders are buying or selling RAPT Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data RAPT Institutional Buying and Selling by Quarter Ad DTI[PDF] The Opportunity in GoldCommodities expert, Geof Smith, insists that the supercycle on gold is just getting warmed up. In fact, even though gold looks like this since he initially called a major bull run 11 months ago… He’s still predicting it will be the TOP trade of 2025. His free eBook explains why You see, the last time gold launched into a supercycle like this it surged 536% The time before that was over 1,000%... That’s why Geof released this urgent guide to help you. Most people think they’ve missed out, but he thinks we’re at the very beginning of what could be the largest gold rally of our lifetimes. But, believe it or not, Geof doesn’t think you should just buy and hold precious metals. He’ll share more about his approach inside the eBook and it might surprise you.Tap here to read it RAPT Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails12/26/2024 JPMorgan Chase & Co.16,703$34K0.0%-298.2%0.048% 11/19/2024 Barclays PLC39,729$79K0.0%+277.2%0.114% 11/15/2024 Barclays PLC39,729$79K0.0%+277.2%0.114% 11/15/2024 Jane Street Group LLC66,515$134K0.0%-66.9%0.191% 11/15/2024 Readystate Asset Management LP18,074$36K0.0%N/A0.052% 11/15/2024 Redmile Group LLC504,532$1.01M0.1%-6.0%1.446% Get the Latest News and Ratings for RAPT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for RAPT Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/15/2024 Point72 Asset Management L.P.525,221$1.06M0.0%-25.7%1.505% 11/14/2024 PDT Partners LLC36,998$74K0.0%-62.2%0.106% 11/14/2024 Walleye Capital LLC101,163$203K0.0%-12.6%0.290% 11/12/2024 Charles Schwab Investment Management Inc.70,946$143K0.0%-65.9%0.203% 11/4/2024 Los Angeles Capital Management LLC201,439$405K0.0%+138.1%0.577% 10/10/2024 Exchange Traded Concepts LLC89,076$179K0.0%+244.7%0.255% 9/16/2024 Point72 DIFC Ltd8,697$27K0.0%-83.1%0.025% 8/19/2024 Point72 Asset Management L.P.707,300$2.16M0.0%+176,725.0%2.027% 8/16/2024 Algert Global LLC47,483$145K0.0%-11.9%0.136% 8/15/2024 The Manufacturers Life Insurance Company25,325$77K0.0%-30.0%0.073% 8/15/2024 AQR Capital Management LLC88,373$270K0.0%N/A0.253% 8/14/2024 Squarepoint Ops LLC107,994$329K0.0%N/A0.309% 8/14/2024 Cubist Systematic Strategies LLC295,241$900K0.0%+826.4%0.846% 8/14/2024 Point72 DIFC Ltd8,697$27K0.0%-83.1%0.025% 8/12/2024 XTX Topco Ltd35,480$108K0.0%N/A0.102% 8/9/2024 Renaissance Technologies LLC203,900$622K0.0%+108.1%0.584% 8/9/2024 Dimensional Fund Advisors LP331,876$1.01M0.0%-40.4%0.951% 8/8/2024 Federated Hermes Inc.796,080$2.43M0.0%+188.7%2.281% 8/6/2024 Acadian Asset Management LLC467,182$1.42M0.0%+4,183.3%1.339% 8/6/2024 Los Angeles Capital Management LLC84,586$258K0.0%+66.2%0.242% 7/26/2024 Bank of New York Mellon Corp114,590$349K0.0%+24.0%0.328% 7/20/2024 Hennion & Walsh Asset Management Inc.48,525$148K0.0%+8.6%0.139% 5/16/2024 Kingdon Capital Management L.L.C.1,500,000$13.47M1.5%+55.3%4.298% 5/16/2024 Redmile Group LLC662,398$5.95M0.2%+80.6%1.898% 5/15/2024 Price T Rowe Associates Inc. MD2,028,166$18.21M0.0%-40.6%5.811% 5/14/2024 EntryPoint Capital LLC17,907$161K0.1%N/A0.051% 5/10/2024 Acadian Asset Management LLC10,907$97K0.0%N/A0.031% 5/10/2024 Vanguard Group Inc.2,492,850$22.39M0.0%+21.2%7.163% 5/1/2024 Mirae Asset Global Investments Co. Ltd.12,652$114K0.0%-38.6%0.036% 4/29/2024 China Universal Asset Management Co. Ltd.6,602$59K0.0%+65.8%0.019% 4/19/2024 Denali Advisors LLC32,600$293K0.1%N/A0.094% 4/5/2024 Los Angeles Capital Management LLC50,894$457K0.0%+442.7%0.146% 3/18/2024 Kingdon Capital Management L.L.C.965,828$24.00M3.0%+19.9%2.775% 2/26/2024 Perceptive Advisors LLC2,139,950$53.18M1.2%+11.4%6.221% How Low-Cost Stocks Generate Monthly Income (Ad)Are you ready to transform your investment strategy and generate a steady monthly income? We’re excited to offer you our exclusive report, "Options Trading Strategy: 2 (Surprisingly) Low-Cost Stocks Primed for Generating Monthly Income," FREE!👉 Yes, I Want the Free Report! 👈2/15/2024 Octagon Capital Advisors LP292,000$7.26M1.2%N/A0.849% 2/15/2024 Great Point Partners LLC1,099,753$27.33M4.7%-24.6%3.197% 2/14/2024 Braidwell LP389,300$9.67M0.4%-64.0%1.132% 2/14/2024 Artia Global Partners LP19,638$488K0.1%N/A0.057% 2/14/2024 CenterBook Partners LP31,447$781K0.1%N/A0.091% 2/13/2024 Rafferty Asset Management LLC91,553$2.28M0.0%-6.7%0.266% 2/12/2024 TD Asset Management Inc117,618$2.92M0.0%-23.4%0.342% 2/12/2024 Chesapeake Capital Corp IL10,212$254K0.2%N/A0.030% 2/7/2024 TimesSquare Capital Management LLC504,340$12.53M0.2%N/A1.466% 2/6/2024 Charles Schwab Investment Management Inc.234,439$5.83M0.0%+5.7%0.682% 2/6/2024 Los Angeles Capital Management LLC9,378$233K0.0%N/A0.027% 2/6/2024 Swiss National Bank44,000$1.09M0.0%-10.4%0.128% 1/30/2024 Zurcher Kantonalbank Zurich Cantonalbank3,919$97K0.0%-22.9%0.011% 1/24/2024 China Universal Asset Management Co. Ltd.3,981$99K0.0%+347.8%0.012% 1/12/2024 SG Americas Securities LLC9,801$244K0.0%N/A0.028% 1/5/2024 Exchange Traded Concepts LLC7,190$179K0.0%+34.0%0.021% 12/18/2023 Vanguard Group Inc.2,023,305$33.63M0.0%+3.9%5.882% 12/6/2023 Citigroup Inc.41,660$692K0.0%-6.5%0.121% 12/1/2023 Euclidean Capital LLC657,899$10.93M2.4%+15.2%1.912% 11/15/2023 Redmile Group LLC427,490$7.11M0.3%-1.0%1.244% 11/15/2023 Kingdon Capital Management L.L.C.805,828$13.39M1.5%-19.4%2.345% 11/14/2023 Braidwell LP1,082,512$17.99M0.6%+10.0%3.151% 11/14/2023 Schonfeld Strategic Advisors LLC135,045$2.24M0.0%+75.4%0.393% 11/14/2023 Fred Alger Management LLC85,775$1.43M0.0%-45.9%0.250% 11/14/2023 Profund Advisors LLC16,734$278K0.0%-27.8%0.049% 11/13/2023 Algert Global LLC61,991$1.03M0.0%-17.8%0.180% 11/13/2023 FMR LLC4,499,293$74.78M0.0%+7.4%13.095% 11/13/2023 Rafferty Asset Management LLC98,159$1.63M0.0%-22.9%0.286% 11/9/2023 Citigroup Inc.41,660$692K0.0%-6.5%0.121% 11/8/2023 Swiss National Bank49,100$816K0.0%+9.6%0.143% 11/7/2023 Barclays PLC53,651$892K0.0%-16.7%0.156% 10/27/2023 Hennion & Walsh Asset Management Inc.40,565$674K0.0%+89.5%0.118% 10/27/2023 TD Asset Management Inc153,618$2.55M0.0%+67.4%0.447% 10/26/2023 Mirae Asset Global Investments Co. Ltd.20,547$341K0.0%-5.6%0.060% 10/18/2023 Exchange Traded Concepts LLC5,366$89K0.0%-18.7%0.016% 9/21/2023 Barclays PLC64,436$1.21M0.0%+28.8%0.188% 8/24/2023 Perceptive Advisors LLC2,288,493$42.80M1.2%-0.1%6.661% 8/15/2023 Braidwell LP984,400$18.41M0.6%N/A2.866% 8/14/2023 Cormorant Asset Management LP325,000$6.08M0.3%-50.0%0.946% 8/14/2023 Great Point Partners LLC1,465,151$27.40M5.4%+8.1%4.265% 8/14/2023 Deep Track Capital LP1,004,561$18.79M0.9%+75.9%2.924% 8/10/2023 Profund Advisors LLC23,181$433K0.0%+11.3%0.067% 8/9/2023 TD Asset Management Inc91,787$1.72M0.0%-1.8%0.267% 8/8/2023 Candriam S.C.A.313,262$5.86M0.0%-5.2%0.912% 8/3/2023 Los Angeles Capital Management LLC28,748$538K0.0%-68.5%0.084% 8/3/2023 Barclays PLC64,436$1.21M0.0%+28.8%0.188% 8/3/2023 Bank of New York Mellon Corp94,565$1.77M0.0%+1.7%0.275% 7/20/2023 Exchange Traded Concepts LLC6,599$123K0.0%N/A0.019% 7/14/2023Cheyne Capital Management UK LLP20,000$374K1.4%N/A0.058% 5/16/2023 Great Point Partners LLC1,355,151$24.87M4.9%-5.7%3.946% Last time you’ll see this priced at $1.00 (Ad)When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds for a dollar anymore!Click here to review Tim’s special Holiday offer before it’s too late.5/16/2023 Boxer Capital LLC300,000$5.51M0.3%N/A0.873% 5/15/2023 Kingdon Capital Management L.L.C.875,984$16.07M3.0%-0.5%2.555% 5/12/2023 Profund Advisors LLC20,823$382K0.0%N/A0.061% 5/11/2023 FMR LLC4,455,840$81.77M0.0%+50.9%12.996% 5/11/2023 Citigroup Inc.111,116$2.04M0.0%+29.2%0.324% 5/9/2023 California State Teachers Retirement System36,450$669K0.0%+3.0%0.106% 5/8/2023 Federated Hermes Inc.17,509$321K0.0%N/A0.051% 5/8/2023 Zurcher Kantonalbank Zurich Cantonalbank5,083$93K0.0%+683.2%0.015% 5/4/2023 Barclays PLC50,034$917K0.0%-37.2%0.146% 5/4/2023 Mirae Asset Global Investments Co. Ltd.16,688$306K0.0%+40.9%0.049% (Data available from 1/1/2016 forward) RAPT Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of RAPT shares? During the previous two years, 61 institutional investors and hedge funds held shares of RAPT Therapeutics. The most heavily invested institutionals were FMR LLC ($74.78M), Perceptive Advisors LLC ($53.18M), Great Point Partners LLC ($27.33M), Vanguard Group Inc. ($22.39M), Deep Track Capital LP ($18.79M), Price T Rowe Associates Inc. MD ($18.21M), and Kingdon Capital Management L.L.C. ($13.47M).Learn more on RAPT's institutional investors. What percentage of RAPT Therapeutics stock is owned by institutional investors? 99.09% of RAPT Therapeutics stock is owned by institutional investors. Learn more on RAPT's institutional investor holdings. Which institutional investors have been buying RAPT Therapeutics stock? Of the 48 institutional investors that purchased RAPT Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Braidwell LP ($2.08M), FMR LLC ($1.81M), Kingdon Capital Management L.L.C. ($898.56K), Point72 Asset Management L.P. ($706.90K), Federated Hermes Inc. ($537.88K), Vanguard Group Inc. ($512.99K), and TimesSquare Capital Management LLC ($504.34K). How much institutional buying is happening at RAPT Therapeutics? Institutional investors have bought a total of 11,063,498 shares in the last 24 months. This purchase volume represents approximately $159.56M in transactions. Which RAPT Therapeutics major shareholders have been selling company stock? Of the 30 institutional investors that sold RAPT Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Price T Rowe Associates Inc. MD ($1.39M), Braidwell LP ($693.21K), Great Point Partners LLC ($439.74K), Cormorant Asset Management LP ($325K), Dimensional Fund Advisors LP ($224.93K), Kingdon Capital Management L.L.C. ($198.19K), and Point72 Asset Management L.P. ($182.08K). How much institutional selling is happening at RAPT Therapeutics? Institutional investors have sold a total of 4,363,574 shares in the last 24 months. This volume of shares sold represents approximately $59.66M in transactions. Related Companies Aurora Cannabis Institutional Ownership Zentalis Pharmaceuticals Institutional Ownership Lexeo Therapeutics Institutional Ownership DiaMedica Therapeutics Institutional Ownership ProQR Therapeutics Institutional Ownership LifeVantage Institutional Ownership SOPHiA GENETICS Institutional Ownership Inhibrx Institutional Ownership Aclaris Therapeutics Institutional Ownership Opthea Institutional Ownership This page (NASDAQ:RAPT) was last updated on 12/27/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RAPT Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share RAPT Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
